4
Changes in Ownership
PROTHENA CORP PUBLIC LTD CO Filed Acc 0001140361-22-039911
Director sold 15,833 shares at an average $62.88 ($995,658)
- Director acquired 15,833 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ekman Lars Director | 2022-11-01 | Option exercise | +15,833 | $6.41 | $101,490 | 16,076 | D: show line 1 in the form |
| Ekman Lars Director | 2022-11-01 | Sale | −9,143 | $62.01 | $566,953 | 6,933 | D: show line 2 in the form |
| Ekman Lars Director | 2022-11-01 | Sale | −1,717 | $62.91 | $108,013 | 5,216 | D: show line 3 in the form |
| Ekman Lars Director | 2022-11-01 | Sale | −3,312 | $64.26 | $212,824 | 1,904 | D: show line 4 in the form |
| Ekman Lars Director | 2022-11-01 | Sale | −1,661 | $64.94 | $107,868 | 243 | D: show line 5 in the form |
| Open-market sales · 15,833 sh · avg $62.88 · $995,658 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ekman Lars Director | 2022-11-01 | Option exercise · Stock Option (right to buy) | −15,833 | 31,668 | D: show line 6 in the form |
Loading xslF345X03/form4.xml…